Publications by authors named "Anthony Schwarer"

59Publications

Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response.

Thromb Haemost 2019 Jul 12;119(7):1112-1123. Epub 2019 May 12.

Thrombosis and Vascular Diseases Laboratory, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.

View Article and Find Full Text PDF
July 2019

A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia.

J Mol Diagn 2017 09 18;19(5):711-721. Epub 2017 Jul 18.

Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia; Australasian Leukaemia and Lymphoma Group, Melbourne, Victoria, Australia; Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, South Australia, Australia; Department of Molecular Medicine and Pathology, Flinders University and Medical Centre, Adelaide, South Australia, Australia. Electronic address:

View Article and Find Full Text PDF
September 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article and Find Full Text PDF
May 2017

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.

Asia Pac J Clin Oncol 2017 Jun 22;13(3):226-233. Epub 2016 Dec 22.

Oncology and Haematology Department, Box Hill Hospital, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
June 2017

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.

Ann Hematol 2016 Apr 15;95(5):809-16. Epub 2016 Feb 15.

Eastern Health, Monash University Clinical School, Melbourne, Australia.

View Article and Find Full Text PDF
April 2016

NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation.

Leuk Res 2016 Apr 17;43:58-65. Epub 2015 Dec 17.

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

View Article and Find Full Text PDF
April 2016

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

Blood 2015 Feb 17;125(6):915-23. Epub 2014 Dec 17.

Department of Haematology, and Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, Australia; Australasian Leukemia and Lymphoma Group, Melbourne, Australia; Cancer Theme, South Australia Health and Medical Research Institute, Adelaide, Australia;

View Article and Find Full Text PDF
February 2015

Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?

Exp Hematol 2015 Mar 27;43(3):149-57. Epub 2014 Nov 27.

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
March 2015

The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation.

Leuk Res 2013 May 6;37(5):516-9. Epub 2013 Feb 6.

Malignant Hematology and Stem Cell Transplantation Service, Alfred Hospital, Monash University, Melbourne, Australia.

View Article and Find Full Text PDF
May 2013

The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.

Iran J Allergy Asthma Immunol 2012 Mar;11(1):15-21

Blood Transfusion Research Centre, Iranian Blood Transfusion Organization, Tehran, Iran.

View Article and Find Full Text PDF
March 2012

Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.

Immunol Cell Biol 2010 Aug 2;88(6):676-84. Epub 2010 Mar 2.

Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Victoria, Australia.

View Article and Find Full Text PDF
August 2010

Telomerase in cancer immunotherapy.

Biochim Biophys Acta 2010 Jan 12;1805(1):35-42. Epub 2009 Sep 12.

Department of Immunology, Central Clinical School, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia.

View Article and Find Full Text PDF
January 2010

Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.

J Immunol 2009 Oct 11;183(7):4502-8. Epub 2009 Sep 11.

Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia.

View Article and Find Full Text PDF
October 2009

Malignant melanoma mimicking acute leukemia.

J Clin Oncol 2009 Aug 1;27(24):e62-4. Epub 2009 Jun 1.

Department of Medical Oncology, Box Hill Hospital, Box Hill, Victoria, Australia.

View Article and Find Full Text PDF
August 2009

Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.

Protein Expr Purif 2008 Sep 14;61(1):22-30. Epub 2008 May 14.

Bone Marrow Transplant Research Laboratory, 1st Floor William Buckland Building, Alfred Hospital, Melbourne, Vic. 3004, Australia.

View Article and Find Full Text PDF
September 2008

The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.

Blood 2007 Dec 21;110(12):4073-6. Epub 2007 Aug 21.

Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article and Find Full Text PDF
December 2007

Expression and purification of the minor histocompatibility antigen, HA-1H generated in Escherichia coli.

Protein Expr Purif 2007 Jul 27;54(1):176-82. Epub 2007 Feb 27.

Immunotherapy Research Group, Bone Marrow Transplant Unit, Alfred Hospital, Melbourne, Australia.

View Article and Find Full Text PDF
July 2007

Renal graft rejection after allogeneic peripheral-blood stem cell transplantation.

Am J Kidney Dis 2006 Nov;48(5):822-6

Department of Renal Medicine, Bone Marrow Transplant Program, Alfred Hospital, Melbourne, Australia.

View Article and Find Full Text PDF
November 2006

Fatal anerobic bacteremia after hematopoietic stem cell transplant.

Leuk Lymphoma 2004 Jan;45(1):143-5

Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Australia.

View Article and Find Full Text PDF
January 2004